Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
Bayssas M, Gouveia J, Ribaud P, Musset M, de Vassal F, Pico JL, de Luca L, Misset JL, Machover D, Belpomme D, Schwarzenberg L, Jasmin C, Hayat M, Mathé G.
Bayssas M, et al. Among authors: schwarzenberg l.
Cancer Chemother Pharmacol. 1979;2(4):247-55. doi: 10.1007/BF00257189.
Cancer Chemother Pharmacol. 1979.
PMID: 287569